Scientists at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C), they report in Clinical Care Explorations. MIS-C is a rare but severe and potentially life-threatening condition that usually develops in children weeks to months after they have experienced a mild...
Tag: <span>COVID-19 complication</span>
Post
Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 complications, mild to moderate
BMJ Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 complications, mild to moderate Side effects clear up quickly in this group, findings show Study numbers small, but data representative of those most likely to benefit The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to...